5 interviews. 5 minutes. The asthma data from ATS 2026 your patients will be asking about.
Simon Couillard, MD
Advertisement
Simon Couillard, MD, FRCPC, MSc, from Université de Sherbrooke.
Articles by Simon Couillard, MD
At ATS 2026, Couillard discussed a win ratio analysis showing dupilumab significantly improved remission outcomes, particularly among patients with elevated eosinophils and FeNO.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
The HCPFive: Top News for Healthcare Providers from the Week of 07/05
2
All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study
3
The Rosacea Misconception Clinicians Still Hear Every Day
4
Early Signs of Scarring Alopecia, Pipeline Outlook, With Bejamin Ungar, MD
5